EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, In Silico, and Experimental Evaluation of Novel Naproxen–Azetidinone Hybrids as Selective COX-2 Inhibitors

Ayad Kareem Khan iD, Noor Riyadh Mahmood iD, Mohammed Abdulaali Sahib iD

Molecules · 2025

DOI: 10.3390/molecules30224358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Ayad Kareem Khan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, Mustansiriyah University, Baghdad 10052, Iraq. Hauptthemen laut MEDLINE: Naproxen, Cyclooxygenase 2 Inhibitors, Cyclooxygenase 2, Azetidines. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The therapeutic use of non-steroidal anti-inflammatory drugs (NSAIDs) is limited by gastrointestinal and renal adverse effects caused by non-selective COX-1 and COX-2 inhibition. To address this issue, a new series of naproxen–azetidinone hybrids was rationally designed and synthesized to enhance COX-2 selectivity and reduce off-target toxicity. The synthesis involved esterification, hydrazide formation, Schiff base condensation, and intramolecular cyclization with chloroacetyl chloride. Structural characterization was achieved through FT-IR, 1H NMR, and 13C NMR analyses. In silico ADMET profiling confirmed compliance with Lipinski’s rule and predicted favorable gastrointestinal absorption. Molecular docking revealed high COX-2 binding affinities (−11.93 to −9.72 kcal/mol), while MM/GBSA analysis identified compound N4c (ΔG = −62.27 kcal/mol) as the most stable complex, surpassing meloxicam and naproxen. DFT (B3LYP/6-31G(d,p)) frontier molecular orbital analysis indicated a narrow HOMO–LUMO gap (ΔE = 2.97 eV) for N4c, suggesting high electronic reactivity and strong enzyme interaction. Molecular dynamics simulations confirmed complex stability. In vivo anti-inflammatory testing using an egg-white-induced rat paw edema model showed that N4d, N4e, and N4f achieved higher inhibition (19.22%, 16.98%, and 16.98%) than naproxen (4.3%). These results highlight 2-azetidinone–naproxen hybrids as promising selective COX-2 inhibitors with enhanced pharmacokinetic and electronic properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaproxenCyclooxygenase 2 InhibitorsCyclooxygenase 2AzetidinesDrug DesignAnimalsMolecular Docking SimulationRatsAnti-Inflammatory Agents, Non-SteroidalEdemaMaleMolecular StructureHumansStructure-Activity Relationship

Stichwörter der Autor:innen

COX-2 inhibitionDFT analysisMM/GBSAanti-inflammatory activityazetidinone hybridsmolecular dockingmolecular dynamics simulation

Substanzen

NaproxenCyclooxygenase 2 InhibitorsCyclooxygenase 2Azetidines2-azetidinoneAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, College of Pharmacy, Mustansiriyah University, Baghdad 10052, Iraq.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, University of Kerbala, Karbala 56001, Iraq.

ORCID-Profile: Ayad Kareem Khan, Noor Riyadh Mahmood, Mohammed Abdulaali Sahib

Zitieren

APA

Khan, A. K., Mahmood, N. R., & Sahib, M. A. (2025). Design, In Silico, and Experimental Evaluation of Novel Naproxen–Azetidinone Hybrids as Selective COX-2 Inhibitors. Molecules. https://doi.org/10.3390/molecules30224358

Vancouver

Khan AK, Mahmood NR, Sahib MA. Design, In Silico, and Experimental Evaluation of Novel Naproxen–Azetidinone Hybrids as Selective COX-2 Inhibitors. Molecules. 2025. doi:10.3390/molecules30224358

BibTeX
@article{Khan2025,
  author = {Khan, Ayad Kareem and Mahmood, Noor Riyadh and Sahib, Mohammed Abdulaali},
  title = {Design, In Silico, and Experimental Evaluation of Novel Naproxen–Azetidinone Hybrids as Selective COX-2 Inhibitors},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30224358}
}
Kostenlos starten →